Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Japan, November 20, 2008 - Astellas Pharma Inc. (headquarters: Tokyo, president and CEO: Masafumi Nogimori, “Astellas”) announced today that an injectable antibiotic, in-licensed from...
Read more about Astellas Announces the Outcome of FDA's Advisory Committee in the US for Telavancin
Japan, November 18, 2008 - Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced that it has established its subsidiary, Astellas Pharma India...
Read more about Astellas Establishes a Marketing Subsidiary in India
Japan, November 5, 2008 – Astellas Pharma Inc. (Headquarters: Tokyo; President and CEO: Masafumi Nogimori, hereinafter called the “the Company”) announced that at the meeting of the Board of...
Read more about Astellas Announces Acquisition of Treasury Stock
Japan, October 27, 2008 - Astellas Pharma Inc. (headquarters: Tokyo, president and CEO: Masafumi Nogimori, “Astellas”) today announced that its immunosuppressant Graceptor® Capsules 0.5mg,...
Read more about Astellas Launches the Immunosuppressant Graceptor®in Japan
Follow us
